Allogeneic Platelet-Rich Plasma: At the Dawn of an Off-the-Shelf Therapy?  Eduardo Anitua, Roberto Prado, Gorka Orive  Trends in Biotechnology  Volume 35, Issue 2, Pages 91-93 (February 2017) DOI: 10.1016/j.tibtech.2016.11.001 Copyright © 2016 Elsevier Ltd Terms and Conditions

Figure 1 Comparison of the Two Different Procedures for Preparing Platelet-Rich Plasma (PRP). (A) Briefly, peripheral venous blood from a patient is withdrawn into tubes. The blood is centrifuged to separate PRP from other blood components. PRP can subsequently be applied as different formulations with therapeutic potential to treat the pathology of the same patient, such as the osteoarthritis of the knee, as shown in the figure. (B) By contrast, allogeneic PRP is obtained from the peripheral blood of one or more healthy donors, and off-the-shelf PRP is prepared and preserved until application. The same batch of this type of PRP may be used to treat a single patient over time or to treat several different patients. Trends in Biotechnology 2017 35, 91-93DOI: (10.1016/j.tibtech.2016.11.001) Copyright © 2016 Elsevier Ltd Terms and Conditions